Dialysis membrane-induced oxidative stress: Role of heme oxygenase-1

Nephron - Experimental Nephrology

Volumn 105, Issue 1, 2006, Pages

  Bhaskaran, Madhu ^a   Radhakrishnan, Neetu ^a   Patni, Hitesh ^a   Singh, Priyanka ^a   Chaudhary, Ahmad N ^a   Singhal, Pravin C ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b Division of Kidney Disease and Hypertension   (United States)

Author keywords

Heme oxygenase 1; Hemodialysis; Oxidative stress

Indexed keywords

HEME OXYGENASE 1; HEMIN; PROTOPORPHYRIN TIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

APOPTOSIS; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DIALYSIS MEMBRANE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTIOXIDANTS; APOPTOSIS; CELLULOSE; DNA FRAGMENTATION; HEME OXYGENASE-1; HEMIN; HUMANS; LIPID PEROXIDATION; MEMBRANES, ARTIFICIAL; MONOCYTES; OXIDATIVE STRESS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 33845727648     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097016     Document Type: Article

References (33)

1. Das M, Aronow WS, McClung JA, Belkin RN: Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency. Cardiol Rev 2006;14:14-17.
2. Fort J: Chronic renal failure: a cardiovascular risk factor. Kidney Int Suppl 2005;99:S25-S29.
3. Vaziri ND: Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004;24:469-473.
4. Manning RD Jr, Tian N, Meng S: Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 2005;25:311-317.
5. Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV: Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int 2005;68:173-178.
6. Nahar N, Shah H, Siu J, Colvin R, Bhaskaran M, Ranjan R, Wagner JD, Singhal PC: Dialysis membrane-induced neutrophil apoptosis is mediated through free radicals. Clin Nephrol 2001;56:52-59.
7. Jaber BL, Balakrishnan VS, Cendoroglo MN, Perianayagam MC, King AJ, Pereira BJ: Modulation of neutrophil apoptosis by uremic plasma during hemodialysis. Blood Purif 1998;16:325-335.
8. Galli F, Ghibelli L, Buoncristiani U, Bordoni V, D'Intini V, Benedetti S, Canestrari F, Ronco C, Floridi A: Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E. Nephrol Dial Transplant 2003;18:1592-1600.
9. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H: Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005;20:2775-2782.
10. Heidenreich S, Schmidt M, Bachmann J, Harrach B: Apoptosis of monocytes cultured from long-term hemodialysis patients. Kidney Int 1996;49:792-799.
11. Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC, deFrancisco AL, Lopez-Hoyos M, Arias M: B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Trans 2000;15:502-510.
12. Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S, Rodriguez M, Aljama P: Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol 2000;11:936-942.
13. Jaber BL, Cendoroglo M, Balakrishnan VS, Perianayagam, King AJ, Pereira BJ: Apoptosis of leukocytes: basic concepts and implication in uremia. Kidney Int Suppl 2001;78:S197-S205.
14. Ranjan R, Shah H, Siu J, Varghese E, Bhaskaran M, Reddy K, Kapasi AA, Wagner JD, Singhal PC: Monocyte apoptosis in dialysis patients is Fas ligand mediated. Clin Nephrol 2002;58:423-430.
15. Bhaskaran M, Ranjan R, Shah H, Siu J, Colvin R, Radhakrishnan N, Reddy K, Franki N, Wagner, JD, Singhal PC: Lymphopenia in dialysis patients: a preliminary study indicating a possible role of apoptosis. Clin Nephrol 2002;57:221-229.
16. D'Intini V, Bordoni V, Fortunato A, Galloni E, Carta M, Galli F, Bolgan I, Inguaggiato P, Poulin S, Bonello M, Tetta C, Levin N, Ronco C: Longitudinal study of apoptosis in chronic uremic patients. Semin Dial 2003;16:467-473.
17. Bordoni V, Piroddi M, Galli F, de Cal M, Bonello M, Dimitri P, Salvatori G, Ranishta R, Levin N, Tetta C, Ronco C: Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif 2006;24:149-156.
18. Sardenberg C, Suassuna P, Andreoli MC, Watanabe R, Dalboni MA, Manfredi SR, dos Santos OP, Kallas EG, Draibe SA, Cendoroglo M: Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006;21:160-165.
19. Willis D, Moore AR, Frederick R Willoughby DA: Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 1996;2:87-90.
20. Nath KA: Heme oxygenase-1: a redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest 1999;104:1485-1486.
21. Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM: Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol 1996;14:556-568.
22. Yoshida T, Biro P, Cohen T, Muller RM, Shibahara S: Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem 1998;171:457-461.
23. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, Jacob HS: Exposure of endothelial cells to free heme potentates damage mediated by granulocytes and toxic oxygen species. Lab Invest 1991;64:648-655.
24. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercllotti GM: Endothelial cell-heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 1993;90:9285-9289.
25. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS: Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;59:879-888.
26. Biasioli S, Schiavon R, Petrosino L, Cavallini L, Cavalcanti G, De Fanti E, Zambello A, Borin D: Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia and oxidative stress. ASAIO J 2000;46:625-634.
27. Clermont G, Lecour S, Lahet J, Siohan P, Vergely C, Chevet D, Rifle G, Rochette L: Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc Res 2000;47:618-623.
28. Hirayama A, Nagase S, Gotoh M, Ueda A, Ishizu T, Yoh K, Aoyagi K, Terao J, Koyama A: Reduced serum hydroxyl radical scavenging activity in erythropoietin therapy resistant renal anemia. Free Radic Res 2002;36:1155-1161.
29. Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F: Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif 1999;17:99-106.
30. Lucchi L, Bergamini S, Botti B, Rapana R, Ciuffreda A, Ruggiero P, Ballestri M, Tomasi A, Albertazzi A: Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress. Artif Organs 2000;24:1-6.
31. Zima T, Haragsim L, Stipek S, Bartova V, Nemecek K: Lipid peroxidation on dialysis membranes. Biochem Mol Biol Int 1993;29:531-537.
32. Calo LA, Naso A, Pagnin E, Davis PA, Castoro M, Corradin R, Riegler P, Cascone C, Huber W, Piccoli A: Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis- a molecular biological approach. Clin Nephrol 2004;62:355-361.
33. Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT: Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int 2006;69:706-714.